Haemonetics Corporation

NYSE:HAE

Sector

🏥 Health Care

Industries

🏥 Hospitals & Clinics

🩺 Medical Instruments

💻 Software & Operating Systems

Location

United States

Market Cap

USD 3.64 B

Share Price

USD 75.86

Avg Daily Volume

556,751

Change (1 day)

0.42%

Change (1 year)

-14.70%

Change (YTD)

-2.84%

Haemonetics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 29, 2025: USD 181.72 M

Haemonetics Corporation Operating Cash Flow is USD 181.72 M for the Trailing 12 Months (TTM) ending March 29, 2025, a -0.01% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Haemonetics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 30, 2024 was USD 181.75 M, a -33.44% change year over year.
Haemonetics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending April 01, 2023 was USD 273.06 M, a 58.51% change year over year.
Haemonetics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending April 02, 2022 was USD 172.26 M, a 58.32% change year over year.
Haemonetics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending April 03, 2021 was USD 108.81 M, a -31.23% change year over year.